Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-07762-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849238523112062976 |
|---|---|
| author | Jacques Fantini Fodil Azzaz Anaïs Aulas Henri Chahinian Nouara Yahi |
| author_facet | Jacques Fantini Fodil Azzaz Anaïs Aulas Henri Chahinian Nouara Yahi |
| author_sort | Jacques Fantini |
| collection | DOAJ |
| format | Article |
| id | doaj-art-2b73cd01a9114d439ece13bcf27ecb4b |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-2b73cd01a9114d439ece13bcf27ecb4b2025-08-20T04:01:35ZengNature PortfolioScientific Reports2045-23222025-07-011511310.1038/s41598-025-07762-4Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53Jacques Fantini0Fodil Azzaz1Anaïs Aulas2Henri Chahinian3Nouara Yahi4Aix Marseille Univ, INSERM UA16Aix Marseille Univ, INSERM UA16AmyPoreAix Marseille Univ, INSERM UA16Aix Marseille Univ, INSERM UA16https://doi.org/10.1038/s41598-025-07762-4 |
| spellingShingle | Jacques Fantini Fodil Azzaz Anaïs Aulas Henri Chahinian Nouara Yahi Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 Scientific Reports |
| title | Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 |
| title_full | Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 |
| title_fullStr | Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 |
| title_full_unstemmed | Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 |
| title_short | Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53 |
| title_sort | correction preclinical assessment of a ganglioside targeted therapy for parkinson s disease with the first in class adaptive peptide amyp53 |
| url | https://doi.org/10.1038/s41598-025-07762-4 |
| work_keys_str_mv | AT jacquesfantini correctionpreclinicalassessmentofagangliosidetargetedtherapyforparkinsonsdiseasewiththefirstinclassadaptivepeptideamyp53 AT fodilazzaz correctionpreclinicalassessmentofagangliosidetargetedtherapyforparkinsonsdiseasewiththefirstinclassadaptivepeptideamyp53 AT anaisaulas correctionpreclinicalassessmentofagangliosidetargetedtherapyforparkinsonsdiseasewiththefirstinclassadaptivepeptideamyp53 AT henrichahinian correctionpreclinicalassessmentofagangliosidetargetedtherapyforparkinsonsdiseasewiththefirstinclassadaptivepeptideamyp53 AT nouarayahi correctionpreclinicalassessmentofagangliosidetargetedtherapyforparkinsonsdiseasewiththefirstinclassadaptivepeptideamyp53 |